Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

Ivim Health Tirzepatide Review: Cost, an Unclear Membership Fee & Honest Verdict (2026)

An honest 2026 review of Ivim Health tirzepatide — a published 6-month commitment rate, a free first month, and a membership fee worth clarifying.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

Eden

Compounded tirzepatide at a low headline price, billed on top of a recurring membership.

$199/mo + $99/mo membership

FDA warning letter
FDA issued Eden Health International Inc. dba Eden a warning letter in June 2026 (False & Misleading Claims/Misbranded (Telehealth)). Read the letter on FDA’s own warning-letter database.

Check Eden availability

Ivim Health: $224/month for tirzepatide month-to-month, dropping to $133/month on a published 6-month commitment — both figures present on the site, along with a $75 figure tied to a separately marketed membership. Every fact here comes from the company's own published program.

What Ivim Health is

Ivim Health is a telehealth weight-loss program, selling compounded semaglutide and tirzepatide, each quoted as medication and program charges included rather than as a bare drug price. The first month of membership is free.

§ Ivim Health — Pricing and the Unclear Membership Fee

ItemDetail
Tirzepatide, month-to-month$224/mo
Tirzepatide, 6-month plan$133/mo
Membership fee$75 — relationship to medication price unclear
Verified: $224/mo month-to-month, $133/mo on 6-month plan, $75 membership marketed separately.

What Ivim Health costs

$224/month month-to-month for tirzepatide, dropping to $133/month on a published 6-month commitment — the term length is stated rather than hidden, a real positive. A $75 membership is also marketed on the site.

An unclear membership fee — worth asking directly

This is the most important thing to clarify before signing up: it's not stated anywhere on the site whether the $75 membership is charged on top of the $149 (or $224) medication rate, or whether it's bundled into the quoted price. Ask directly before assuming the headline medication price is your total monthly cost.

The brand-vs-compounded question

Ivim Health dispenses compounded tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Ivim Health's real strengths: both molecules priced with program charges included rather than as bare drug prices, a published, non-hidden 6-month term for the discounted rate, and a free first month of membership. The trade-offs: the $75 membership's relationship to the medication price is unclear, the $133/month rate requires a 6-month commitment (month-to-month is $224), and both figures are "starting at" rates — a titrated dose's actual cost isn't published. As with any GLP-1 program, get direct written confirmation of whether the membership fee stacks on top of the medication price before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Ivim Health's published commitment terms and free first month are genuine positives, but the relationship between its $75 membership and the medication price is genuinely unclear from the public site — get that confirmed in writing before signing up. For a provider with a single, unambiguous all-in price, compare it against CoreAge Rx or Harper Meds. For another provider whose headline price this review found was a promotional rate rather than the real therapeutic-dose cost, see Measured. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

How much does tirzepatide cost through Ivim Health?

$224/month month-to-month, dropping to $133/month on a published 6-month commitment.

Is Ivim Health's $75 membership charged on top of the medication price?

Unclear — this review found no statement anywhere on the site confirming whether the $75 membership stacks on top of the medication rate or is bundled into it. Ask directly.

Is the first month of Ivim Health free?

Yes — the first month of membership is free.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

Related monograph sections

View all sections